Insider Transactions in Q3 2021 at Repare Therapeutics Inc. (RPTX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
887
-0.03%
|
$29,271
$33.93 P/Share
|
|
Sep 07
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
887
-0.03%
|
$29,271
$33.93 P/Share
|
|
Sep 03
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,197
-0.22%
|
$244,698
$34.0 P/Share
|
|
Sep 03
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,197
-0.22%
|
$244,698
$34.0 P/Share
|
|
Sep 02
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
16,424
-0.5%
|
$558,416
$34.24 P/Share
|
|
Sep 02
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
16,424
-0.5%
|
$558,416
$34.24 P/Share
|
|
Sep 01
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
12,968
-0.39%
|
$427,944
$33.98 P/Share
|
|
Sep 01
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
12,968
-0.39%
|
$427,944
$33.98 P/Share
|
|
Aug 31
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
8,472
-0.26%
|
$279,576
$33.94 P/Share
|
|
Aug 31
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
8,472
-0.26%
|
$279,576
$33.94 P/Share
|
|
Aug 30
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
6,697
-0.2%
|
$221,001
$33.92 P/Share
|
|
Aug 30
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
6,697
-0.2%
|
$221,001
$33.92 P/Share
|
|
Aug 27
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,093
-0.21%
|
$234,069
$33.94 P/Share
|
|
Aug 27
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,093
-0.21%
|
$234,069
$33.94 P/Share
|
|
Aug 26
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
4,283
-0.13%
|
$145,622
$34.52 P/Share
|
|
Aug 26
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
4,283
-0.13%
|
$145,622
$34.52 P/Share
|
|
Aug 25
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,082
-0.21%
|
$240,788
$34.34 P/Share
|
|
Aug 25
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,082
-0.21%
|
$240,788
$34.34 P/Share
|
|
Aug 24
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
4,039
-0.12%
|
$137,326
$34.07 P/Share
|
|
Aug 24
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
4,039
-0.12%
|
$137,326
$34.07 P/Share
|
|
Aug 23
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,094
-0.21%
|
$241,196
$34.06 P/Share
|
|
Aug 23
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,094
-0.21%
|
$241,196
$34.06 P/Share
|
|
Aug 18
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
5,860
-0.08%
|
$193,380
$33.99 P/Share
|
|
Aug 18
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
2,930
-0.08%
|
$96,690
$33.99 P/Share
|
|
Aug 17
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
34,796
-0.52%
|
$1,183,064
$34.12 P/Share
|
|
Aug 17
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
17,398
-0.52%
|
$591,532
$34.12 P/Share
|
|
Aug 16
2021
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-21.77%
|
$510,000
$34.21 P/Share
|
|
Aug 05
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,539
-100.0%
|
-
|
|
Aug 05
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
4,539
+50.0%
|
-
|
|
Aug 05
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
152,071
-39.68%
|
-
|
|
Aug 05
2021
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
156,610
-79.89%
|
-
|
|
Aug 05
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
4,539
+50.0%
|
-
|
|
Aug 05
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
19
+0.16%
|
-
|
|
Aug 05
2021
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
156,610
-79.89%
|
-
|
|
Aug 05
2021
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
4,539
+50.0%
|
-
|
|
Jul 12
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
58,012
-0.74%
|
$1,914,396
$33.84 P/Share
|
|
Jul 12
2021
|
Todd Foley Director |
SELL
Open market or private sale
|
Indirect |
25,559
-0.56%
|
$843,447
$33.84 P/Share
|
|
Jul 09
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,067
-0.1%
|
$134,211
$33.06 P/Share
|
|
Jul 09
2021
|
Todd Foley Director |
SELL
Open market or private sale
|
Indirect |
1,792
-0.08%
|
$59,136
$33.06 P/Share
|